In Vitro Study Presented at DEUEL Conference on Lipids Suggests Combination Omega-3 Fatty Acid EPA and Atorvastatin May Provide Atheroprotective Benefit - the combo can actually reverse atherosclerosis!
The patent filing:
Also, a little puzzled that AMRN goes up +5% after announcing 20% dilution secondary this morning? Wonder if market is happy now that they have likely ensured having enough cash to finish REDUCE-IT? And that the sword of dilution that has been hanging over our heads is now out of the way, uncertainty gone, a relief to the market?